CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.83+0.05 (+6.00%)
Close on Nov 18, 2026Market cap $9.82MP/E –Yield –
CytoMed Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
CytoMed Therapeutics's price to sales ratio was 39.3× on Nov 11, 2026, against 395.8× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 39.3× | −245.8 |
| 2025 | Dec 31, 2025 | 285.0× | – |
See a number that looks wrong?